MEX3A Impairs DNA Mismatch Repair Signaling and Mediates Acquired Temozolomide Resistance in Glioblastoma.
Tian GanYan WangManyi XieQiang WangSaisai ZhaoPeng WangQinyu ShiXuanchen QianFaan MiaoZhigang ShenEr NiePublished in: Cancer research (2022)
A MEX3A/CCR4-NOT/MSH2 axis plays a crucial role in promoting temozolomide resistance, providing new insights into the function of MEX3A and suggesting MEX3A as a potential therapeutic target in therapy-resistant glioblastoma.